Research progress on burden of disease of tuberculosis

Abstract

Abstract: With the changing and developing of China’s tuberculosis control situation, the concept and evaluation method of burden of disease of tuberculosis need to be updated accordingly. This article reviewed the recent international and domestic researches on burden of disease of tuberculosis, the methods and results were discussed and their advantages and disadvantages were described as a reference for developing tuberculosis control policy.

Key words: Tuberculosis, Cost of illness, Evaluation studies

BAI Li-qiong，XIAO Shui-yuan, ZHANG Yi-rui, JIN Shui-gao, CHENG Shi-min. Research progress on burden of disease of tuberculosis[J]. Chinese Journal of Antituberculosis, 2013, 35(1): 77-80.

References

［1］Murray CJ, Lopez AD. Global and regional cause of death patterns in 1990. Bull World Health Organ，1994, 72（3）:447-480.

［2］周尚成,蔡乐,万崇华.疾病经济负担研究方法学探讨.国际医药卫生导报, 2005, (5)：27-29.

［3］Hyder AA, Rotllant G, Morrow RH. Measuring the burden of disease: healthy life-years. Am J Pub Health, 1998, 88（2）:196-202.

［4］Murray CJL, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ，1994, 72（3）:495-509.

［5］吕繁,曾光.疾病负担评价的理论框架及其发展.中华流行病学杂志，2001, 22(4)：259-261.

［6］World Health Organization.Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. WHO/HTM/TB/2009.411.Geneva:World Health Organization,2009.

［7］Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet,1997, 349（9061）: 1269-1276.

［8］Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life year. Bull World Health Organ,1994, 72（3）:429-445.

［9］Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press, 1996.

［10］WHO. Mental health: new understanding, new hope. Geneva: World Health Organization, 2001.

［11］World Health Organization. Global burden of disease (GBD) 2000: Version 3 estimates［DB/OL］. 2003 ［2012-10-12］. http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2000_v3/en/

［12］全国结核病流行病学抽样调查技术指导组，全国结核病流行病学抽样调查办公室.2000年全国结核病流行病学抽样调查报告.中国防痨杂志,2002,24(2):65-108

［13］World Health Organization.Global tuberculosis control: surveillance, planning, financing: WHO report 2008. WHO/HTM/TB/2008.393.Geneva: World Health Organization,2008.

［14］World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2004. WHO/HTM/TB/2004.331. Geneva:World Health Organization,2004: 63-66.

［15］World Health Organization.Global tuberculosis control: surveillance, planning, financing. WHO report 2005. WHO/HTM/TB/2005.349. Geneva:World Health Organization:2005:75-78.

［16］World Health Organization.Global tuberculosis control: surveillance, planning, financing. WHO report 2006. WHO/HTM/TB/2006.362. Geneva:World Health Organization,2006: 83-85.

［17］World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva: World Health Organization,2007: 89-92.

［18］严非，刘晓云，赵新平，等.当前农村肺结核病人费用负担分析.中国卫生资源,2006，9（4）：164-166.

［19］王国杰，马士文,谢春雨，等.河南省贫困地区DOTS策略下肺结核费用及其影响因素调查.现代预防医学,2007， 34（7）)：1236-1239.

［20］方春福，王承敏，王敏，等. 衢州市肺结核病人住院及住院费用流行病学调查.中国农村卫生事业管理，2006，26（12）：41-44.

［21］魏伟，萧新生.我国结核病的疾病负担研究.国际医药卫生导报，2009，15（8）：5-7.

［22］马进，张毓辉，孔巍,等.2001年哈尔滨市肺结核疾病负担研究.中国卫生经济，2003，22（7）：27-29.

［23］武桂英,龚幼龙,李玉梅，等.结核病控制项目疾病经济负担研究.中华医院管理杂志， 2001,17(12)：713-716.

［24］徐旭卿.耐药肺结核病的卫生经济学评价［J/OL］.中国优秀硕士学位论文全文数据库.2006:12-14 ［2012-10-10］. http://cdmd.cnki.com.cn/Article/CDMD.10335.2006074381.htm.

［25］王雪静,武桂英,龚幼龙,等. 结核病控制项目地区耐药结核病病人的经济负担研究. 中国卫生经济, 2005, 24(3)：49-51.

［26］龚幼龙，万利亚，武桂英.结核病控制经济与管理学评价.上海：第二军医大学出版社，2003.

［27］van Leth F,van der Werf MJ,Borgdorff MW. Prevalence of tuberculous infection and incidence of tuberculosis; a reassessment of the Styblo rule. Bull World Health Organ,2008,86(1):20-26.

［28］何铁牛.初复治肺结核病人家庭及社会经济负担比较分析.现代预防医学，2006，33（11）：2134-2135.

［29］Dye C. Breaking a law: tuberculosis disobeys Styblo’s rule. Bull World Health Organ,2008, 86 (1):4.

［30］张立兴，阚冠卿.结核病传染性的问题.国外医学内科学分册，1975，（10）：440-443.

［31］许群，乌正赉，金水高,等.初治涂阳肺结核病人及其传染性所致疾病负担的评价方法研究.卫生研究，2003，32（6）：558-561.

[1]	LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
[2]	Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of fixed-dose combination formulations [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893.
[3]	JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902.
[4]	ZHANG Can-you, XIA Hui, CHENG Jun. Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
[5]	ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915.
[6]	LIU Er-yong, WANG Qian, ZHOU Lin, ZHANG Guo-qin, ZHANG Xiu-lei, MA Yong-cheng, YANG Shu-min, WANG Cui, MENG Qing-lin, CHEN Ming-ting, LIN Ming-gui, TU De-hua.. Analysis of diagnostic quality of pulmonary tuberculosis with negative etiology in some areas of China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 916-920.
[7]	MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925.
[8]	WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia.. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930.
[9]	LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936.
[10]	LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941.
[11]	SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947.
[12]	DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng.. Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955.
[13]	DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961.
[14]	MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
[15]	NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei. Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980.